AFP and hepatocellular carcinoma: Moreover, the diagnostic and prognosticsensitivity of AFP was poor in the early stage of HCC, especially when used alone.Here, we evaluated the clinical usefulness of KMO as a prognostic factor in HCCpatients with AFP < 20 ng/ml, which accounted for 36.1%of HCC patients in our study cohort.